301 related articles for article (PubMed ID: 28382490)
1. Silencing of Y-box binding protein-1 by RNA interference inhibits proliferation, invasion, and metastasis, and enhances sensitivity to cisplatin through NF-κB signaling pathway in human neuroblastoma SH-SY5Y cells.
Wang H; Sun R; Chi Z; Li S; Hao L
Mol Cell Biochem; 2017 Sep; 433(1-2):1-12. PubMed ID: 28382490
[TBL] [Abstract][Full Text] [Related]
2. shRNA-Mediated Silencing of Y-Box Binding Protein-1 (YB-1) Suppresses Growth of Neuroblastoma Cell SH-SY5Y In Vitro and In Vivo.
Wang H; Sun R; Gu M; Li S; Zhang B; Chi Z; Hao L
PLoS One; 2015; 10(5):e0127224. PubMed ID: 25993060
[TBL] [Abstract][Full Text] [Related]
3. Y-box-binding protein 1 promotes tumor progression and inhibits cisplatin chemosensitivity in esophageal squamous cell carcinoma.
Xu J; Hu Z
Biomed Pharmacother; 2016 Apr; 79():17-22. PubMed ID: 27044807
[TBL] [Abstract][Full Text] [Related]
4. [Effects of miR-144 on proliferation, apoptosis and cisplatin resistance by targeting MYCN in pediatric neuroblastoma].
Liu HJ; Li GL; Lei PC
Zhonghua Zhong Liu Za Zhi; 2019 Jul; 41(7):516-521. PubMed ID: 31357838
[No Abstract] [Full Text] [Related]
5. The increased expression of Y box-binding protein 1 in melanoma stimulates proliferation and tumor invasion, antagonizes apoptosis and enhances chemoresistance.
Schittek B; Psenner K; Sauer B; Meier F; Iftner T; Garbe C
Int J Cancer; 2007 May; 120(10):2110-8. PubMed ID: 17266041
[TBL] [Abstract][Full Text] [Related]
6. Identification of 2,4-dihydroxy-5-pyrimidinyl imidothiocarbomate as a novel inhibitor to Y box binding protein-1 (YB-1) and its therapeutic actions against breast cancer.
Gunasekaran VP; Nishi K; Sivakumar D; Sivaraman T; Mathan G
Eur J Pharm Sci; 2018 Apr; 116():2-14. PubMed ID: 28916481
[TBL] [Abstract][Full Text] [Related]
7. 2,2',4,4'-Tetrabromodiphenyl ether promotes human neuroblastoma SH-SY5Y cells migration via the GPER/PI3K/Akt signal pathway.
Tian PC; Wang HL; Chen GH; Luo Q; Chen Z; Wang Y; Liu YF
Hum Exp Toxicol; 2016 Feb; 35(2):124-34. PubMed ID: 25784559
[TBL] [Abstract][Full Text] [Related]
8. YBX1 gene silencing inhibits migratory and invasive potential via CORO1C in breast cancer in vitro.
Lim JP; Shyamasundar S; Gunaratne J; Scully OJ; Matsumoto K; Bay BH
BMC Cancer; 2017 Mar; 17(1):201. PubMed ID: 28302118
[TBL] [Abstract][Full Text] [Related]
9. Cx43 Mediates Resistance against MPP⁺-Induced Apoptosis in SH-SY5Y Neuroblastoma Cells via Modulating the Mitochondrial Apoptosis Pathway.
Kim IS; Ganesan P; Choi DK
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27809287
[TBL] [Abstract][Full Text] [Related]
10. Combination of gamma-interferon with TRAIL and cisplatin or etoposide induces apoptosis in human neuroblastoma cell line SH-SY5Y.
Tong HX; Lu CW; Zhang JH; Ma L; Zhang JH
Chin Med Sci J; 2007 Mar; 22(1):38-43. PubMed ID: 17441316
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of survivin by siRNA inhibits invasion and promotes apoptosis in neuroblastoma SH-SY5Y cells.
Zhang L; Liang H; Cao W; Xu R; Ju XL
Braz J Med Biol Res; 2014 Jul; 47(7):548-53. PubMed ID: 24863648
[TBL] [Abstract][Full Text] [Related]
12. The human endonuclease III enzyme is a relevant target to potentiate cisplatin cytotoxicity in Y-box-binding protein-1 overexpressing tumor cells.
Guay D; Garand C; Reddy S; Schmutte C; Lebel M
Cancer Sci; 2008 Apr; 99(4):762-9. PubMed ID: 18307537
[TBL] [Abstract][Full Text] [Related]
13. Triptolide Inhibits Proliferation and Migration of Human Neuroblastoma SH-SY5Y Cells by Upregulating MicroRNA-181a.
Jiang J; Song X; Yang J; Lei K; Ni Y; Zhou F; Sun L
Oncol Res; 2018 Sep; 26(8):1235-1243. PubMed ID: 29426375
[TBL] [Abstract][Full Text] [Related]
14. p53 Suppresses lung resistance-related protein expression through Y-box binding protein 1 in the MCF-7 breast tumor cell line.
Tian B; Liu J; Liu B; Dong Y; Liu J; Song Y; Sun Z
J Cell Physiol; 2011 Dec; 226(12):3433-41. PubMed ID: 21344396
[TBL] [Abstract][Full Text] [Related]
15. [Pt(O,O'-acac)(γ-acac)(DMS)] alters SH-SY5Y cell migration and invasion by the inhibition of Na+/H+ exchanger isoform 1 occurring through a PKC-ε/ERK/mTOR Pathway.
Muscella A; Vetrugno C; Calabriso N; Cossa LG; De Pascali SA; Fanizzi FP; Marsigliante S
PLoS One; 2014; 9(11):e112186. PubMed ID: 25372487
[TBL] [Abstract][Full Text] [Related]
16. YB-1 expression promotes pancreatic cancer metastasis that is inhibited by microRNA-216a.
Lu J; Li X; Wang F; Guo Y; Huang Y; Zhu H; Wang Y; Lu Y; Wang Z
Exp Cell Res; 2017 Oct; 359(2):319-326. PubMed ID: 28782557
[TBL] [Abstract][Full Text] [Related]
17. Y-box binding protein 1 is up-regulated in proliferative breast cancer and its inhibition deregulates the cell cycle.
Yu YN; Yip GW; Tan PH; Thike AA; Matsumoto K; Tsujimoto M; Bay BH
Int J Oncol; 2010 Aug; 37(2):483-92. PubMed ID: 20596676
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-141 and its associated gene FUS modulate proliferation, migration and cisplatin chemosensitivity in neuroblastoma cell lines.
Wang Z; Lei H; Sun Q
Oncol Rep; 2016 May; 35(5):2943-51. PubMed ID: 26936280
[TBL] [Abstract][Full Text] [Related]
19. Intracellular localization and content of YB-1 protein in multidrug resistant tumor cells.
Vaiman AV; Stromskaya TP; Rybalkina EY; Sorokin AV; Guryanov SG; Zabotina TN; Mechetner EB; Ovchinnikov LP; Stavrovskaya AA
Biochemistry (Mosc); 2006 Feb; 71(2):146-54. PubMed ID: 16489918
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin regulates SH-SY5Y cell growth through downregulation of BDNF via miR-16.
Sun YX; Yang J; Wang PY; Li YJ; Xie SY; Sun RP
Oncol Rep; 2013 Nov; 30(5):2343-9. PubMed ID: 24026226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
